Photo: <a href="https://depositphotos.com" target="_blank">Depositphotos</a>
Sep 23, 2025, 06:06
Fibroblast Activation Protein: A New Driver of Pulmonary Hypertension
Journal of Cardiovascular Pharmacology posted on X:
”Fibroblast Activation Protein: A New Driver of Pulmonary Hypertension”
Read the full article here.
Title: FAP Promotes Pulmonary Artery Hypertension via Activation of the PTEN/PI3K/Akt Pathway
Authors: Minghui Zhu, Fei Xu, Le Zhu, Qianqian Chen, Xiaomin Jiang, Chang Pan, Wande Yu, Hang Zhang
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage